✦ LIBER ✦

5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor

✍ Scribed by Stock, Nicholas S.; Bain, Gretchen; Zunic, Jasmine; Li, Yiwei; Ziff, Jeannie; Roppe, Jeffrey; Santini, Angelina; Darlington, Janice; Prodanovich, Pat; King, Christopher D.

Book ID: 111686785
Publisher: American Chemical Society
Year: 2011
Tongue: English
Weight: 610 KB
Volume: 54
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm2008369

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Lipoxygenase-activating protein inhibi

5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration

✍ Nicholas Stock; Christopher Baccei; Gretchen Bain; Charles Chapman; Lucia Correa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 343 KB

AM643 (compound 6, 3-{3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid) was identified as a potential candidate for formulation as a topical agent for the treatment of skin disorders involving leukotriene producti

ChemInform Abstract: 5-Lipoxygenase-Acti

ChemInform Abstract: 5-Lipoxygenase-Activating Protein Inhibitors. Part 2. 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy) -3-tert-butylsulfanyl-1- [4-(5-methoxy-pyrimidin-2-yl)-benzyl] -1H-indol-2-yl}-2,2-dimethyl-propionic Acid (AM679) — A Potent FLAP Inhibitor.

✍ Nicholas Stock; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views